New Zealand markets closed

Eli Lilly and Company (LLY)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
935.02+14.13 (+1.53%)
At close: 04:00PM EDT
935.06 +0.04 (+0.00%)
After hours: 07:58PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
38,922,800
34,124,100
28,541,400
28,318,400
24,539,800
Cost of revenue
7,491,800
7,082,200
6,629,800
7,312,800
5,483,300
Gross profit
31,431,000
27,041,900
21,911,600
21,005,600
19,056,500
Operating expenses
Research development
10,205,800
9,313,400
7,190,800
6,930,700
6,085,700
Selling general and administrative
7,337,000
6,941,200
6,067,500
6,141,900
5,869,400
Total operating expenses
17,542,800
16,254,600
13,258,300
13,072,600
11,955,100
Operating income or loss
13,888,200
10,787,300
8,653,300
7,933,000
7,101,400
Interest expense
626,000
485,900
331,600
339,800
359,600
Total other income/expenses net
-4,449,400
-3,920,400
-1,578,100
-1,463,100
455,100
Income before tax
8,989,300
6,554,600
6,806,400
6,155,500
7,229,900
Income tax expense
1,647,100
1,314,200
561,600
573,800
1,036,200
Income from continuing operations
7,342,200
5,240,400
6,244,800
5,581,700
6,193,700
Net income
7,342,200
5,240,400
6,244,800
5,581,700
6,193,700
Net income available to common shareholders
7,342,200
5,240,400
6,244,800
5,581,700
6,193,700
Basic EPS
5.54
5.83
6.57
5.85
6.47
Diluted EPS
5.52
5.80
6.57
5.85
6.47
Basic average shares
900,536
899,379
950,182
953,653
956,590
Diluted average shares
903,569
903,284
950,182
953,653
956,590